Baxter International
OverviewSuggest Edit
Baxter International is a provider of critical care, nutrition, renal, hospital, and surgical products. The company offers acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, and surgical hemostat and sealant products. Its products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, and by patients at home under physician supervision.
| Type | Public | |
| Founded | 1931 | |
| HQ | Deerfield, IL, US | Map |
| Website | baxter.com | |
| Employee Ratings | More | |
| Overall Culture | A | More |
Recent NewsAll News
- Insights on the Lyophilized Injectable Global Market to 2031 - Featuring Baxter International, BD and Aristopharma Among Others
- Worldwide Disposable Medical Supplies Industry to 2030 - Featuring 3M, Baxter International and Bayer Among Others
- Daily Dividend Report: Conagra Brands, Fastenal, Baxter International, AON, Duke Energy
- Insights on the Infusion Therapy Global Market to 2026 - Featuring Pfizer, Baxter International and Option Care Health Among Others
Key People/Management at Baxter International
José E. Almeida
Giuseppe Accogli
Wil Boren
Dennis Crowley
David Bondi
Stacey Eisen
Baxter International Office Locations
Baxter International Financials and Metrics
Baxter International Revenue
| USD | |
|---|---|
Revenue (Q1, 2021) | 2.9b |
Gross profit (Q1, 2021) | 1.1b |
Gross profit margin (Q1, 2021), % | 38.9% |
Net income (Q1, 2021) | 300.0m |
EBIT (Q1, 2021) | 390.0m |
Market capitalization (2-Aug-2021) | 38.8b |
Closing stock price (2-Aug-2021) | 77.2 |
Cash (31-Mar-2021) | 3.2b |
EV | 36.5b |
| USD | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 389.0m | 732.0m | 1.3b | 347.0m | 690.0m | 1.0b | 333.0m | 580.0m | 939.0m | 300.0m |
Depreciation and Amortization | 192.0m | 387.0m | 594.0m | 195.0m | 393.0m | 580.0m | 199.0m | 401.0m | 610.0m | 217.0m |
Inventories | (56.0m) | (134.0m) | (236.0m) | (82.0m) | (91.0m) | (88.0m) | (83.0m) | (261.0m) | (305.0m) | (129.0m) |
Accounts Payable | (103.0m) | (109.0m) | (51.0m) | (310.0m) | (308.0m) | (249.0m) | (110.0m) | (48.0m) | 36.0m | 22.0m |
| USD | FY, 2017 |
|---|---|
Revenue/Employee | 224.7k |
Debt/Equity | 0.4 x |
Debt/Assets | 0.2 x |
Financial Leverage | 1.9 x |
Baxter International Acquisitions / Subsidiaries
| Company Name | Date | Deal Size |
|---|---|---|
| Cheetah Medical | September 10, 2019 | $230 m |
| ApaTech Limited | ||
| Baxter AO | ||
| Baxter Belgium SPRL | ||
| Baxter (China) Investment Co., Ltd | ||
| Baxter Company Ltd | ||
| Baxter Corporation (Canada) | ||
| Baxter Corporation Englewood | ||
| Baxter de Guatemala, Sociedad Anonima | ||
| Baxter Deutschland GmbH |
Baxter International Revenue Breakdown
Baxter International revenue breakdown by business segment: 7.7% from Advanced Surgery, 7.7% from Clinical Nutrition, 19.0% from Pharmaceuticals, 24.6% from Medication Delivery, 32.0% from Renal Care and 9.0% from Other
Baxter International revenue breakdown by geographic segment: 53.6% from Americas, 26.1% from EMEA and 20.2% from APAC
Baxter International Cybersecurity Score
Baxter International Environment, Social & Governance (ESG) Ratings
Baxter International Online and Social Media Presence
14.96k Twitter followers
Baxter International has 14.96k Twitter Followers. The number of followers has increased 0.2% month over month
Baxter International's Trends
Twitter Engagement Stats for @baxter_intl
1.9k
Tweets
2
Following
15k
Followers
13
Tweets last 30 days
6.9
Avg. likes per Tweet
92.3%
Tweets with engagement
Baxter International Company Culture
Overall Culture
A
75/100
CEO Rating
A+
80/100
Compensation
A+
100/100
Baxter International News and Updates
Insights on the Lyophilized Injectable Global Market to 2031 - Featuring Baxter International, BD and Aristopharma Among Others
Worldwide Disposable Medical Supplies Industry to 2030 - Featuring 3M, Baxter International and Bayer Among Others
Daily Dividend Report: Conagra Brands, Fastenal, Baxter International, AON, Duke Energy
Insights on the Infusion Therapy Global Market to 2026 - Featuring Pfizer, Baxter International and Option Care Health Among Others
$83 Billion End Stage Renal Disease Global Market to 2026 - Featuring Nipro, Fresenius Medical Care and Baxter International Among Others
Global Infusion Pumps Market (2021 to 2025) - Leading Players Include Pfizer, Fresenius and Baxter International
Baxter International Frequently Asked Questions
When was Baxter International founded?
Baxter International was founded in 1931.
Who are Baxter International key executives?
Baxter International's key executives are José E. Almeida, Giuseppe Accogli and Wil Boren.
How many employees does Baxter International have?
Baxter International has 50,000 employees.
What is Baxter International revenue?
Latest Baxter International annual revenue is $11.7 b.
What is Baxter International revenue per employee?
Latest Baxter International revenue per employee is $233.5 k.
Who are Baxter International competitors?
Competitors of Baxter International include Abbott, Becton Dickinson and Medtronic.
Where is Baxter International headquarters?
Baxter International headquarters is located at 1 Baxter Pkwy, Deerfield.
Where are Baxter International offices?
Baxter International has offices in Deerfield, Marion, Opelika, Round Lake and in 66 other locations.
How many offices does Baxter International have?
Baxter International has 75 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies